Search Results

Eli Lilly and Co. became the first drug company to make public its grants to U.S. organizations by posting the records on its Web site today. Most of the grants focus on endocrinology, neurosciences, oncology and other areas where Lilly develops drugs. The largest in the first quarter was to Massachusetts General Hospital’s Department of […]

Indiana Supreme Court Chief Justice Randall T. Shepard will speak in place of Randall Tobias at commencement ceremonies Sunday for the Indiana University School of Law–Indianapolis, according to the Indiana Lawyer. Tobias, a former CEO at Eli Lilly, resigned late last month as a deputy secretary of state in the Bush administration over an alleged […]

Eli Lilly and Co. said today it has hired Alex M. Azar II as senior vice president of corporate affairs and communications. Azar comes to Lilly from the U.S. Department of Health and Human Services, where he was a deputy overseeing the Food and Drug Administration, the Centers for Medicare and Medicaid Services, the National […]

The Corporate Library has named Eli Lilly and Co. among a dozen large companies that have the most pronounced gap between stock performance and compensation of CEOs. Lilly chief executive Sidney Taurel was paid a total of $27.4 million in the past two years, but the five-year return on Lilly stock was a negative 24.6 […]

Eli Lilly and Co. said today that it has become the second corporation, after IBM, to make public a policy forbidding using employees’ genetic information to discriminate in employment choices or eligibility for benefits. The Indianapolis pharmaceutical maker said employees are more likely to take part in individual healthcare programs if they’re assured information from […]

Stephen Goldsmith has taken a director position of a new infrastructure finance and investment group created by Capital Source, a Chevy Chase, Md., investment and asset management group. The new unit will buy and finance long-term transportation, utility and recreation assets in the United States, Capital Source said today. During two terms as Indianapolis mayor […]

Carmel drug developer Marcadia Biotech has received a $15 million venture capital investment from Frazier Healthcare Ventures of Seattle and locally based Twilight Venture Partners. The funding will help Marcadia develop projects including a glucagon analog for emergency treatment of hypoglycemia, the company announced today. Marcadia, which is led by former senior executives of Eli Lilly […]

Eli Lilly and Co. could benefit from a recent New England Journal of Medicine report that Avandia, GlaxoSmithKline’s diabetes drug, might heighten the risk of heart attacks by 43 percent, according to Forbes. Lilly and a Japanese partner have developed Actos, which is similar to Avandia. However, unlike GlaxoSmithKline’s drug, Actos doesn’t make a big […]

Three counterfeit batches of Zyprexa, Eli Lilly and Co.’s blockbuster schizophrenia drug, have been discovered in the supply chain in the United Kingdom, according to Reuters. The product has been recalled by the U.K.’s Medicines and Healthcare Products Regulatory Agency to err on the side of caution even though the agency thinks only two batches […]

Eli Lilly and Co. said today it has bought Ivy Animal Health Inc. for an undisclosed price. The Overland Park, Kan., company, which primarily sells cattle growth promotants, will compliment Lilly’s Elanco animal health arm, Lilly said. The deal is expected to close in the second quarter and result in a charge to earnings of […]